Biogen (BIIB) Other financing activities (2009 - 2026)

Biogen's Other financing activities history runs 18 years deep, the most recent figure standing at $11.3 million for Q1 2026.

• In Q1 2026, Other financing activities rose 769.23% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $15.0 million (up 350.0% YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
• Other financing activities was $11.3 million for Q1 2026 at Biogen, up from -$1.3 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $11.3 million in Q1 2026 to a low of -$17.8 million in Q4 2022.
• Historically, Other financing activities has averaged $276470.6 across 5 years, with a median of $1.3 million in 2025.
• Biggest YoY gain for Other financing activities was 3550.0% in 2024; the steepest drop was 604.0% in 2024.
• A 5-year view of Other financing activities shows it stood at -$17.8 million in 2022, then surged by 42.7% to -$10.2 million in 2023, then surged by 164.71% to $6.6 million in 2024, then sank by 119.7% to -$1.3 million in 2025, then surged by 969.23% to $11.3 million in 2026.
• The last three Other financing activities figures came in at $11.3 million (Q1 2026), -$1.3 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.